Treatment of gastroesophageal reflux disease: two new oral formulations dexlansoprazole MR and esomezol (esomeprazole strontium)

Author： Parekh Parth J Oldfield Edward C Johnson David A

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.15, Iss.9, 2014-06, pp. : 1215-1222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Esomeprazole: In Gastroesophageal Reflux Disease in Children and Adolescents

By Croxtall Jamie D. Perry Caroline M. Keating Gillian M.

Pediatric Drugs, Vol. 10, Iss. 3, 2008-01 ,pp. : 199-205

Adis International

Access to resources Recommend Favorite

New insights into the treatment of gastroesophageal reflux disease

By Campo Salvatore MA

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 10, 2002-10 ,pp. : 1503-1515

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Gastroesophageal Reflux Disease*

By Pettit Michael

Pharmacy World and Science, Vol. 27, Iss. 6, 2005-12 ,pp. : 432-435

Springer Publishing Company

Access to resources Recommend Favorite

Gastroesophageal Reflux Disease in Children with Asthma: Treatment Implications

By Scarupa Mark D.

Pediatric Drugs, Vol. 7, Iss. 3, 2005-01 ,pp. : 177-186

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease

By Storr Martin Meining Alexander Allescher Hans-Dieter

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 7, 2001-07 ,pp. : 1099-1108

Informa Healthcare

Access to resources Recommend Favorite